Table 4.

Summary of additional outcomes

	Number of studies	Testosterone treatment group	Placebo group
Diabetes or diabetes complications	2	14/752 (1·9%)	19/751 (2·5%)
Prostate cancer	8	10/1293 (0·8%)	3/1059 (0·3%)
Oedema	7	34/1301 (2·6%)	17/1290 (1·3%)
Hypertension	7	28/1195 (2·3%)	20/1182 (1·7%)
High haematocrit	7	30/1079 (2·8%)	5/993 (0·5%)
Venous thromboembolism	4	5/1037 (0·5%)	7/1034 (0·7%)
Non-stroke cerebrovascular pathology*	3	4/655 (0·6%)	11/648 (1·7%)

Data are n/N (%).

^*Examples include carotid occlusion and carotid stenosis.